The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Popov D.A.

Bakulev National Medical Research Center for Cardiovascular Surgery

Borovkova U.L.

Bakulev National Medical Research Center for Cardiovascular Surgery

Rybka M.M.

Bakulev National Medical Research Center for Cardiovascular Surgery

Ramnenok T.V.

Bakulev National Medical Research Center for Cardiovascular Surgery

Golukhova E.Z.

Bakulev National Medical Research Center for Cardiovascular Surgery

Predictive value of proadrenomedullin in patients with COVID-19

Authors:

Popov D.A., Borovkova U.L., Rybka M.M., Ramnenok T.V., Golukhova E.Z.

More about the authors

Read: 2463 times


To cite this article:

Popov DA, Borovkova UL, Rybka MM, Ramnenok TV, Golukhova EZ. Predictive value of proadrenomedullin in patients with COVID-19. Russian Journal of Anesthesiology and Reanimatology. 2020;(6‑2):6‑12. (In Russ.)
https://doi.org/10.17116/anaesthesiology20200626

Recommended articles:
New aspe­cts of psoriasis pathogenesis: meta­bolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):526-531
Predictors of aortic valve dysfunction after the Ozaki procedure. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):624-628
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medi­cine. 2024;(12):145-150

References:

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of Medical Virology. 2020;92(4):401-402.  https://doi.org/10.1002/jmv.25678
  2. Coronavirus disease (COVID-19) pandemic. Accessed September 20, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  3. Karakioulaki M, Stolz D. Biomarkers in Pneumonia-Beyond Procalcitonin. International Journal of Molecular Sciences. 2019;20(8):2004. https://doi.org/10.3390/ijms20082004
  4. Fesenco OV, Sinopalnikov AI. Severe community-acquired pneumonia and prognosis assessment scales. Prakticheskaya pul’monologiya. 2014;2:20-26. (In Russ.).
  5. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochemical and Biophysical Research Communications. 2012;425(3):548-555.  https://doi.org/10.1016/j.bbrc.2012.08.022
  6. Temmesfeld-Wollbrück B, Brell B, Dávid I, Dorenberg M, Adolphs J, Schmeck B, Suttorp N, Hippenstiel S. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Medicine. 2007;33(4):703-710.  https://doi.org/10.1007/s00134-007-0561-y
  7. Bellia C, Agnello L, Lo Sasso B, Bivona G, Raineri MS, Giarratano A, Ciaccio M. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit. Clinical Chemistry and Laboratory Medicine. 2019;57(4):549-555.  https://doi.org/10.1515/cclm-2018-0645
  8. Karakas M, Jarczak D, Becker M, Roedl K, Addo MM, Hein F, Bergmann A, Zimmermann J, Simon TP, Marx G, Lütgehetmann M, Nierhaus A, Kluge S. Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules. 2020;10(8):E1171. https://doi.org/10.3390/biom10081171
  9. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clinical Chemistry. 2005;51(10):1823-1829. https://doi.org/10.1373/clinchem.2005.051110
  10. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium. 2007;14(6):345-351.  https://doi.org/10.1080/10623320701678326
  11. Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Morgenthaler NG, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Critical Care. 2010;14(3):R106. https://doi.org/10.1186/cc9055
  12. Vremennye metodicheskie rekomendacii «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii (COVID-19)», versiya 7 ot 03.06.20). [Elektronnyj resurs].Accessed September 02, 2020. https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_MR_COVID-19_v7.pdf (In Russ.).
  13. National Early Warning Score (NEWS): Standardising the assessment of acute-illness severity in the NHS. Report of a working party. Royal College of Physicians. London: RCP, 2012. [Electronic resource]. Accessed September 02, 2020. https://www.rcplondon.ac.uk/file/32/download?token=5NwjEyTq
  14. Mizgerd JP. Acute lower respiratory tract infection. The New England Journal of Medicine. 2008;358(7):716-727.  https://doi.org/10.1056/NEJMra074111
  15. Kolditz M, Ewig S, Höffken G. Management-based risk prediction in community-acquired pneumonia by scores and biomarkers. The European Respiratory Journal. 2013;41(4):974-984.  https://doi.org/10.1183/09031936.00104412
  16. Ewig S, Bauer T, Richter K, Szenscenyi J, Heller G, Strauss R, Welte T. Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups. The European Respiratory Journal. 2013;41(4):917-922.  https://doi.org/10.1183/09031936.00065212
  17. Eckart A, Hauser SI, Kutz A, Haubitz S, Hausfater P, Amin D, Amin A, Huber A, Mueller B, Schuetz P. Combination of the National Early Warning Score (NEWS) and inflammatory biomarkers for early risk stratification in emergency department patients: results of a multinational, observational study. BMJ Open. 2019;9(1):e024636. https://doi.org/10.1136/bmjopen-2018-024636
  18. Prikaz Departamenta zdravoohraneniya Moskvy ot 08.04.20 №373 «Ob utverzhdenii algoritma dejstvij vracha pri postuplenii v stacionar pacienta s podozreniem na vnebol’nichnuyu pnevmoniyu, novuyu koronavirusnuyu infekciyu (COVID-19), poryadka vypiski iz stacionara pacientov s vnebol’nichnoj pnevmoniej, novoj koronavirusnoj infekciej (COVID-19), dlya prodolzheniya lecheniya v ambulatornyh usloviyah (na domu)». [Elektronnyj resurs]. Accessed September 02, 2020. (In Russ.). https://mosgorzdrav.ru/ru-RU/document/default/download/1227.html
  19. Hohenthal U, Hurme S, Helenius H, Heiro M, Meurman O, Nikoskelainen J, Kotilainen P. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia. Clinical Microbiology and Infection. 2009;15(11):1026-1032. https://doi.org/10.1111/j.1469-0691.2009.02856.x
  20. van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, de Jong PA, Coenen S, Ieven M, Butler CC, Goossens H, Little P, Verheij TJ. Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: Diagnostic study. BMJ. 2013;346:f2450. https://doi.org/10.1136/bmj.f2450
  21. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Critical Care. 2006;10(2):R63.  https://doi.org/10.1186/cc4892
  22. Menendez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos MA, Martínez A, Esquinas C, Ramirez P, Torres A. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009;64(7):587-591.  https://doi.org/10.1136/thx.2008.105312
  23. Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Critical Care. 2006;10(3, article R96). https://doi.org/10.1186/cc4955
  24. Albrich WC, Dusemund F, Rüegger K, Christ-Crain M, Zimmerli W, Bregenzer T, Irani S, Buergi U, Reutlinger B, Mueller B, Schuetz P. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infectious Diseases. 2011;11:112.  https://doi.org/10.1186/1471-2334-11-112

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.